UNSPSC 51294802: Rofelodine

This classification denotes an antidepressant agent with the molecular formula C13H14N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 146D7G2I94, chemically known as 2,6,7,8-tetrahydro-7-phenylpyrrolo(1,2-a)pyrimidin-4(3h)-one but generally known as rofelodine, which bears US NIH Compound Identifier 71152. European Medicines Agency schedules Rofelodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10356MIG.

UNSPSC 51294802 Rofelodine is a Commodity code that does not align with the state and local procurement activity currently tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023—solicits naloxone and safe drug deactivation systems for community health initiatives, not rofelodine. Rofelodine is a cardiovascular pharmaceutical with a distinct clinical profile and supply chain, whereas the Seminole County procurement targets opioid-overdose reversal and drug-disposal infrastructure. The mismatch suggests either a tagging error in the source data or dormant purchasing activity under this code.

No substantive recent procurement activity under UNSPSC 51294802 itself is evident in the dataset. State and local buyers do not currently appear to be soliciting rofelodine through standard competitive bidding channels. If your firm manufactures or distributes rofelodine, direct outreach to state pharmacy benefit managers, state health departments, and county public health agencies would be warranted to identify actual demand and contracting mechanisms—which may operate outside standard UNSPSC-tagged solicitations or through group purchasing organization (GPO) cooperative purchasing agreements rather than individual RFPs or IFBs.